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Background/aim: To evaluate diagnostic efficacy of the apparent diffusion coefficient measurements from tumor (ADCt) and tumor
circumference hyperintensities (ADCtch) in different types of malignant intra-axial brain tumors.
Materials and methods: Between April 2013 and June 2017, 125 patients (52 females (41.6%) and 73 males (58.4%); mean age: 53 years,
age range: 14-81 years), who underwent diffusion-weighted imaging (DWI) with intracranial mass, were retrospectively evaluated. The
mean ADCt and ADCtch values and ratios were measured.
Results: Of the 125 patients, 22 (17.6%) had a low-grade glioma (LGG), 55 (44%) had a high-grade glioma (HGG), 32 (25.6%) had
metastasis, and 16 (12.8%) had lymphoma diagnosis. There was a statistically significant difference in LGG and HGG in terms of mean
ADCt and mean ADCtch values, and ratios. ADCtch values and ratios showed a statistically significant difference in the differentiation of
HGG and metastasis and in the differentiation of HGG and lymphoma. According to ROC curve analysis, a cut-off value of 1.49 × 10−3
mm2/s for the mean ADCtch value generated the best combination of 70% sensitivity and 71% specificity for differentiation of HGGs
and metastasis. The mean ADCtch value had the highest statistical predictive value for differentiation of HGGs and lymphoma with a
sensitivity of 78% and a specificity of 76% for the optimal cut-off value of 0.82 × 10ˉ3 mm²/s.
Conclusion: The mean ADCt ratio allowed reliable differentiation of LGG and high grade brain tumors, including HGGs, metastases,
and lymphoma. The mean ADCtch might be a better imaging biomarker in the differentiation of HHG from metastasis and lymphoma.
Key words: Brain tumors, magnetic resonance imaging, diffusion-weighted imaging, apparent diffusion coefficient

1. Introduction
Magnetic resonance imaging (MRI) plays a critical
role in the preoperative evaluation of brain tumors.
However, since tumor groups generally show similar
signal intensity and contrast enhancement patterns on
brain MRI, advanced MRI studies are needed in terms
of differentiation of tumor groups. Diffusion-weighted
imaging (DWI) is used for the differentiation and
grading of tumors on the basis of cellularity with the
microscopic movement of water protons. The studies
have reported an inverse correlation between cellularity
and apparent diffusion coefficient (ADC) measurement
[1].
It is a known fact that gliomas have regions of different
histological grades within the tumor. Histologically,
the region with the highest grade within the tumor
(cellular atypia, vascularization, mitotic characteristic,
and necrosis) indicates the true grade of the tumor.
Therefore, knowing this region is of great importance in

both predicting prognosis and planning the appropriate
treatment [2].
As a result of local disruption of the blood-brainbarrier, vasogenic edema is present around most brain
tumors. In addition to vasogenic edema, infiltrative cells
are present in the peritumoral region of primary brain
tumors. While high-grade gliomas (HGG) usually grow
infiltratively and invade surrounding tissues, metastasis
and lymphoma exhibit an expansive growth and cause
displacement in tissues rather than invading surrounding
brain tissues [1,3]. The aim of this study is to investigate
the contribution of ADC values measured from the
tumoral and peritumoral regions to differential diagnosis
in primary and metastatic intra-axial brain tumors.
2. Materials and methods
This retrospective study was approved by local ethics
committee (2015-50), and the requirement for patient
informed consent was waived.
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2.1. Study population
Between April 2013 and June 2017, MRI examinations of
183 patients, with a diagnosis of intracranial mass, were
evaluated retrospectively. Patients who had undergone
open surgery and stereotaxic biopsy before MRI and
who received radiotherapy and/or chemotherapy were
excluded from the study. Patients with hemorrhagic mass
(n = 15), multiple masses (n = 13), cystic mass (n = 11),
masses less than 2 cm for optimal DWI recon (n = 11)
on MRI examination, and without pathological diagnosis
(n = 8) were excluded from the study. The inclusion and
exclusion criteria for the study are presented in the flow
diagram (Figure 1).

2.2. Imaging protocol
All MRI examinations were performed with a 1.5 T MRI
system (Symphony; Siemens Medical Systems, Erlangen,
Germany) using a 4-channel head coil. Examinations were
obtained using axial and sagittal T1-weighted spin-echo
(SE) images (TR/TE, 495/9.6; NEX, 1; bandwidth, 300
Hz; matrix, 384 × 512; slice thickness, 5 mm; examination
time, 3:30 min; and FOV, 280 × 83 mm), axial T2- weighted
fast SE images (TR/TE, 4650/98; NEX, 1; bandwidth, 500
Hz; matrix, 384 × 512; slice thickness, 5 mm; examination
time, 1:16 min; and FOV, 280 × 83 mm), and axial fluidattenuated inversion recovery (FLAIR) sequence (TR/
TE, 9580/125; matrix, 384 × 512; slice thickness, 5 mm;

Figure 1. Flow diagram of the participants.
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examination time, 4:11 min; the field of view (FOV), 280
× 83 mm). After the intravenous administration of 0.2 mg/
kg gadolinium, contrast-enhanced T1A SE sequences were
obtained in the axial, coronal, and sagittal planes.
DWI was obtained using a spin-echo sequence in
the transverse plane with the single-shot echo-planar
technique. The imaging parameters were as follows: TR/
TE, 3200/94; bandwidth, 1345 Hz; matrix, 192 × 192;
NEX, 3; slice thickness, 5 mm; interslice gap, 1.5 mm;
examination time, 1:12 min; and FOV, 230 x 230 mm.
The diffusion gradients were encoded in three orthogonal
directions. Three different b values (0, 500 and 1000 s/
mm²) were used for each slice. In all patients, ADC maps
were obtained using the b values of 0 and 1000 s/mm².
2.3. Image analysis
ADC values were manually measured by 2 experienced
radiologists (İ.E. and İ.M.Ç. with 9 and 4 years of
experience, respectively) on the workstation (Leonardo,
Siemens Healthcare) independently of each other, who
were unaware of the clinical knowledge of the patients
and the pathological diagnosis of the masses. We selected
all continuous sections that included enhancing tumor
and the peritumoral region. The lowest ADC areas were
determined by visual inspection. One large and 2 small,
uniform, and round (50–100 mm2), ROIs were drawn
manually to the lowest ADC areas. The ROI with the lowest
ADC was chosen from these ROIs as the minimum ADC
(ADCmin). The ROI with the highest ADC was chosen from
these ROIs as the maximum ADC (ADCmax). The average
of ROIs was recorded as mean ADC (ADCmean). DWI
was used only in qualitative analysis with conventional
MR sequences. ROIs were carefully placed in the most
homogeneous solid tumor area (ADCt) corresponding to
the enhancing area, nonenhancing tumor circumference
hyperintensities (ADCtch), and contralateral normal
white matter (ADCn) on the ADC map. In nonenhancing
tumors, ADCt value was measured by taking the most
homogeneous parts of the tumor into account on the T1
and T2-weighted image. In all regions, mean ADC values
(ADCt, ADCtch, and ADCn) were recorded. The cystic,
necrotic, or hemorrhagic parts of the lesions were not
included in the circular ROI images (Figures 2–5). When
there was discordance in ADC values between radiologists,
consensus was reached by a collaborative decision.
ADC ratios were calculated by dividing ADC values
of tumoral and peritumoral regions by ADC value of
contralateral normal white matter (ADCt/n and ADCtch/n).
2.4. Statistical analysis
Statistical analyses were performed using the SPSS
software, version 21 (IBM Corporation, Armonk, NY,
USA). Interobserver agreement values were determined
using Pearson correlation test with a 95% confidence
interval: 0–0.20 inadequate agreement; 0.21–0.4 slight
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agreement; 0.41–0.6 moderate agreement; 0.61–0.8
substantial agreement, 0.81–1.00 almost perfect agreement,
and 1.00 perfect agreements. ANOVA calculation was
used to determine the statistically significant difference of
the four tumor groups (LGG, HGG, and metastasis and
primary cerebral lymphoma) according to their different
ADC values and ratios. Significance values were tested
based on a 95% confidence interval for the difference
between groups. If the P value was < 0.05, differences were
considered significant. The multiple comparisons Tukey’s
T-procedure was used for further examination of pairwise
differences of significant ADC values. If the P value was <
0.05, differences were considered significant.
In the differentiation of the tumor groups, receiver
operating characteristic (ROC) analysis was used to
determine the threshold value of ADC with the best
sensitivity and specificity combination.
3. Results
The study group consisted of a total of 125 patients (52
females and 73 males) with a mean age of 53 (14–81 years)
years, which had solitary intra-axial brain tumor.
In the histopathological evaluation, 22 (17.6%) patients
were diagnosed with LGG (grade 2 oligodendroglioma =
6, grade 2 astrocytoma = 14, ependymoma = 2), 55 (44%)
patients with HGG (anaplastic oligodendroglioma = 3,
anaplastic astrocytoma = 3, glioblastoma multiforme =
49), and 16 (12.8%) patients were diagnosed with primary
cerebral lymphoma. 32 (25.6%) patients were diagnosed
with metastasis (lung cancer = 18, breast cancer = 5,
malignant melanoma = 2, seminoma= 1, nasopharyngeal
cancer = 1, bladder cancer = 1, cervical cancer = 1,
endometrial cancer = 1, thyroid anaplastic cancer = 1,
colon cancer = 1) (Table 1). Histopathological diagnosis
was present in all primary intracranial masses, lymphomas,
and metastasis cases.
Interobserver agreement values of ADCt and ADCn
were almost perfect (0.82, P < 0.001; and 0.85, P < 0.001,
respectively). Interobserver agreement value of ADCtch
was moderate (0.58, P = 0.024).
There was a statistically significant difference in all
parameters (ADC values and ratios) in 4 tumor groups
with the ANOVA test (P < 0.05) (Table 2). ADCt values
and ratios were higher in the LGG than in the other tumor
groups. ADCtch values and ratios were lower in the HGG
tumors than in the other tumor groups. The lowest ADCt
values were measured in lymphoma.
In the pairwise discrimination tests conducted with the
Tukey’s T-procedure, there was a statistically significant
difference LGG and HGG in terms of mean ADCt and
mean ADCtch values and ratios. Mean ADCt ratios showed
a statistically significant difference in differentiation of
LGG and metastasis. ADCt values and ratios showed a
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Figure 2. The FLAIR axial image of a 32-year-old female. (a) An isointense mass with tumor circumference hyperintensities in the right
temporo-occipital lobe. The mass shows no contrast enhancement (b). On the diffusion-weighted imaging (c), the mass is intermediate
signal intensity. The tumor and tumor circumference are hyperintense on the ADC map (d). The ADC value, measured from the
tumoral region, was 1.51 × 10−3 mm²/s, and the ADC value, measured from the tumor circumference region, was 1.80 × 10−3 mm²/s.
(Histopathological diagnosis: diffuse astrocytoma, WHO grade 2).

statistically significant difference in the differentiation of
LGG and lymphoma and in the differentiation of metastasis
and lymphoma. Finally, ADCtch values and ratios showed
a statistically significant difference in the differentiation
of HGG and metastasis and in the differentiation of HGG
and lymphoma (P < 0.05) (Table 3).

In the pairwise discrimination tests, a ROC analysis
was performed for each single factor ADC value found
statistically significant between both tumor groups. The
most powerful predictive marker to differentiation of LGG
and HGG was the mean ADCt ratio, with a sensitivity of
72% and a specificity of 72% for the optimal cut off value
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Figure 3. The axial T2WI of a 69-year-old male. (a) A heterogeneous hyperintense mass in the right temporal lobe. Tumor circumference
is hyperintense. The lesion has a ring and nodular enhancement on the contrast-enhanced axial T1WI (b). On the diffusion-weighted
imaging (c), while the tumor center is hypointense, its periphery is hyperintense. The tumor circumference is intermediate signal
intensity. On the ADC map (d), the tumor circumference is heterogeneous hyperintense. The ADC value, measured from the tumoral
regions, was 0.99 × 10−3 mm²/s, and the ADC value, measured from the tumor circumference hyperintensities, was 1.38 × 10−3 mm²/s
(Histopathological diagnosis: glioblastoma multiforme, WHO grade 4).

2.06 × 10ˉ³ mm²/s. The most powerful predictive marker
to differentiation of LGG and metastasis was the mean
ADCt ratio, with a sensitivity of 77% and a specificity of
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72% for the cut off value 1.44 × 10−3 mm²/s. The most
powerful predictive marker to differentiation of LGG and
lymphoma was the mean ADCt ratio, with a sensitivity
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Figure 4. The axial T2WI of a 56-year-old male. (a). Shows a hyperintense mass in the right temporal lobe. Tumor circumference is
hyperintense. The lesion is homogeneously enhancing on the postcontrast T1WI (b). On the diffusion-weighted imaging (c), while the
tumor is hyperintense, its circumference is hypointense. The mass is hypointense on the ADC map (d). The tumor circumference is
hyperintense. The ADC value, measured from the tumoral region, was 1.11 × 10−3 mm²/s, and the ADC value, measured from the tumor
circumference hyperintensities, was 2.00 × 10−3 mm²/s (Histopathological diagnosis: lung adenocarcinoma metastasis).

of 90% and a specificity of 94% for the cut off value 1.21
× 10−3 mm²/s. The most powerful predictive marker to
differentiation of HGG and metastasis was the mean
ADCtch value, with a sensitivity of 70% and a specificity
of 71% for the cut off value 1.49 × 10−3 mm²/s. The most

powerful predictive marker to differentiation of HGG and
lymphoma was the mean ADCtch value, with a sensitivity of
78% and a specificity of 76% for the cut off value 0.82 × 10−3
mm²/s. Finally, the most powerful predictive marker to
differentiation of metastasis and lymphoma was the mean
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Figure 5. The axial T2WI of a 79-year-old female. (a) Shows an isointense mass in the right frontal lobe. The lesion is homogeneously
enhancing on the post-contrast T1WI (b). On the diffusion-weighted imaging (c), the mass center shows low signal intensity. The tumor
circumference shows relatively intermediate signal intensity. On the ADC map (d), the tumor is significantly hypointense while its
circumference is hyperintense. The ADC value measured from the tumoral region was 0.48 × 10−3 mm²/s, and the ADC value, measured
from the tumor circumference hyperintensities, was 1.37 × 10−3 mm²/s (Histopathological diagnosis: cerebral lymphoma).

ADCt value, with a sensitivity of 72% and a specificity of
82% for the cut off value 1.13 × 10−3 mm²/s (Figure 6).
4. Discussion
In our study, we evaluated diagnostic performance
with ADC measurements to facilitate the preoperative
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differentiation of malignant intra-axial brain tumors,
which are usually not distinguishable with conventional
MR imaging sequences. ADCt values and ratios were
higher in LGGs than in other tumor groups. Our results
showed that the most important parameter is the mean
ADCt ratio, distinguishing LGGs from high grade brain

EYÜBOĞLU et al. / Turk J Med Sci
Table 1. Pathological diagnoses of brain tumors.
Tumors

n (%)

Subgroups (n)
Oligodendroglioma (n = 6)

LGG

Astrocytoma (n = 14)

22 (17.6%)

Ependymoma (n = 2)
Anaplastic oligodendroglioma (n = 3)

HGG
Lymphoma

Metastases

Anaplastic astrocytoma (n = 3)

55 (44%)

Glioblastoma multiforme (n = 49)

16 (12.8%)

Diffuse large B-cell lymphomas (n = 16)

32 (25.6%)

Lung cancer (n = 18)

Breast cancer (n = 5)

Malignant melanoma (n = 2)

Seminoma (n = 1)

Nasopharyngeal cancer (n = 1)

Bladder cancer (n = 1)

Cervical cancer (n = 1)

Endometrial cancer (n = 1)

Thyroid cancer (n = 1)

Colon cancer (n = 1)

n = number of cases and in between parenthesis given the percentages of cases.
Table 2. Mean ADC values of tumor and tumor circumference hyperintensities in different tumor types, ratio of ADC
value of tumoral, and tumor circumference hyperintensities to contralateral normal white matter ADC value.
LGG

HGG

Metastasis

Lymphoma

P value

ADCt mean

1.238 ± 0.357

0.965 ± 0.238

1.025 ± 0.468

0.744 ± 0.102

< 0.001

ADCt ratio mean

1.726 ± 0.521

1.283 ± 0.351

1.334 ± 0.537

0.972 ± 0.150

< 0.001

ADCtch mean

1.572 ± 0.242

1.373 ± 0.253

1.605 ± 0.186

1.670 ± 0.160

< 0.001

ADCtch ratio mean

2.195 ± 0.346

1.822 ± 0.375

2.128 ± 0.326

2.184 ± 0.287

< 0.001

Note: t = tumor; tch = tumor circumference hyperintensities; ADCt ratio = tumor/contralateral hemisphere.
ADCtch ratio = tumor circumference hyperintensities/contralateral hemisphere. The text in bold shows statistical
significance at the 5% level.
Table 3. Multiple comparisons with Tukey t-Procedure tumor and tumor circumference hyperintensities ADC
values and ratios in different tumor types.
Comparison

Mean ADCt

Mean ADCt ratio

Mean ADCtch

Mean ADCtch ratio

LGG and HGG

0.006

0.000

0.004

0.000

LGG and metastasis

0.086

0.006

0.952

0.898

LGG and lymphoma

0.000

0.000

0.541

0.999

HGG and metastasis

0.842

0.948

0.000

0.001

HGG and lymphoma

0.071

0.044

0.000

0.002

Metastasis and lymphoma

0.023

0.026

0.777

0.949

Note: LGG = low grade glioma; HGG = high grade glioma; t = tumor; tch = tumor circumference hyperintensities.
ADCt ratio = tumor/contralateral hemisphere; ADCtch ratio = tumor circumference hyperintensities/contralateral
hemisphere;
Text in bold shows statistical significance at the 5% level.
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Figure 6. (a). The most powerful predictive marker to differentiate between LGG and HGG was the ADCt ratio; the area under the ROC
curve (AUC) was 0.778 (670-899 with a 95% confidence interval) (b). The most powerful predictive marker to differentiation of LGG
and metastasis was the mean ADCt ratio; the AUC was 0.760 (630-890 with a 95% confidence interval) (c). T
h e most powerful predictive
marker to differentiation of LGG and lymphoma was the mean ADCt ratio; the AUC was 0.968 (919-1017 with a 95% confidence
interval) (d). The most powerful predictive marker to differentiation of HGG and metastasis was the mean ADCtch value; the AUC was
0.7767 (681-887 with a 95% confidence interval) (e). The most powerful predictive marker to differentiation of HGG and lymphoma
was the mean ADCtch value; the AUC was 0.808 (704-912 with a 95% confidence interval) (f). The most powerful predictive marker to
differentiation of metastasis and lymphoma was the mean ADCt value; the AUC was 0.778 (654-914 with a 95% confidence interval).

tumors, including HGGs, metastases, and lymphoma. The
lowest ADCtch values and ratios were measured in HGGs.
According to the ROC curve analysis, a cut-off value of
1.49 × 10−3 mm2/s for the mean ADCtch value generated the
best combination of sensitivity 70% and specificity 71% (P
< 0.05) for differentiation of HGGs and metastasis. The
mean ADCtch value had the highest statistical predictive
value for differentiation of HGGs and lymphoma with a
sensitivity of 78% and a specificity of 76% for the optimal
cut-off value of 0.82 × 10−3 mm²/s. The most powerful
predictive value, for differentiation of metastasis and
lymphoma, was the mean ADCt value, with a sensitivity of
72% and a specificity of 82% for the optimal cut-off value
of 1.13 × 10−3 mm²/s.
DWI has been used to grade or differentiate among
brain tumors on the basis of cellularity. The ADC
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measurements reflect the mobility of the free water
fraction, including extracellular and intracellular water,
within the tissue. Many studies have shown that calculation
of ADC may help in differentiating cerebral tumors [1,4].
In addition, an inverse correlation has been found between
tumor cellularity and ADC values [5,6].
Most brain tumors are surrounded by vasogenic edema
that showing high signal intensity on T2WI. Vasogenic
edema is the most common form of cerebral edema in
brain tumors. There is a tendency for local disruption in
the blood-brain barrier. Due to the increased capillary
permeability and pressure, plasma fluid and protein
accumulate from the vascular space to the extracellular
space. Tumor circumference is pure vasogenic edema in
metastatic brain tumors or lymphoma, and there are no
tumor cells in tumor circumference. On the other hand,

EYÜBOĞLU et al. / Turk J Med Sci
the tumor circumference hyperintensities are infiltrative
edema in high-grade glioma. There are infiltrative tumoral
cells that infiltrate through the blood brain-barrier and
may invade white matter pathways [2].
Several previous studies [7,8] reported that ADC values
were not useful in preoperative grading of glioma. In our
study, the mean ADCt ratio had the highest statistical
predictive value in the differentiation of LGGs and HGGs,
with a sensitivity of 72% and a specificity of 72% for the
optimal cut off value of 2.06 × 10−3 mm²/s. A recent study
on the mean ADC of brain tumors showed that the mean
ADCt values are significantly higher in LGG than in HGG.
The cut off value of 1.40 × 10−3 mm²/s can be considered
an index for ADC to distinguish HGG from LGG. In
addition, they emphasized that standard deviation of ADC
is also substantial in differentiation of LGG and HGG [9].
Cihangiroglu MM et al. [10] compared DWI using high
b-value (b = 3000 s/mm2) to standard b-value (b = 1000
s/mm2) in the preoperative grading of supratentorial
gliomas. They found that ADC parameters derived from
DW-MRI using a high b-value allow a better differential
diagnosis of gliomas, especially for differentiating grades
III and IV, than those derived from DW-MRI using a
standard b-value. A possible reason for this result is that
the tumor boundaries were directly determined by the
DWI maps with b = 3000 s/mm2 [11].
In our study, the mean ADCt ratio had the highest
statistical predictive value in the differentiation LGG and
metastasis, with a sensitivity of 77% and a specificity of
72% for the cut off value of 1.44 × 10−3 mm²/s. The mean
ADCt ratio had the highest statistical predictive value in
the differentiation LGG and lymphoma, with a sensitivity
of 90% and a specificity of 94% for the cut off value of 1.21 ×
10ˉ³ mm²/s. These results show us that tumoral cellularity
is higher in metastasis and lymphoma than in LGG.
There was no statistically significant difference between
LGGs and metastasis, between LGG and lymphoma, and
between metastasis and lymphoma in terms of peritumoral
ADC values and ratios (P > 0.05). These values show us that
there is pure vasogenic edema in the tumor circumference
hyperintensities of LGGs, metastasis, and lymphoma.
The previous studies reported that ADCt values are not
useful in differentiation of HGG and metastasis [12–14].
However, Krabbe et al. and Lee EJ et al. reported that ADCt
value was higher in cerebral metastasis than in HGGs
[6,15]. They stated that the high value in metastases was
due to the high content of intracellular or extracellular
water in metastases compared to gliomas. In our study,
there was no statistically significant difference between
HGG and metastasis in terms of ADCt values and ratios.
HGG typically shows an infiltrative growth pattern
with invasion of the surrounding brain tissues. However,
brain metastasis reveals an expansive growth pattern

and displaces the surrounding brain tissues [15]. Some
researchers hypothesized that ADCtch values could be
used to distinguish infiltrative edema of the glioma from
metastatic vasogenic edema [1,15]. But, some conflicting
results were reported in these studies. Pierre Lemercier
et al. used the gradient of ADC values in the tumor
circumference hyperintensities to differentiate HGG from
metastases. ADC measurements were made in areas near,
an intermediate distance from, and far from the coreenhancing tumor (G1, G2, and G3). They found a gradient
of ADC in the peritumoral edema of glioblastoma
associated with peritumoral glial alterations [3]. While,
Eun Ja Lee et al. reported that the mean minimum ADC
values and mean ADC ratios in the tumor circumference
of glioblastomas were significantly higher than those in
metastases [15], Ionut Caravan et al. reported that the mean
ADCmin values in the tumoral circumference of HGGs
were significantly lower than those in brain metastases
[16]. These conflicting results revealed that assessment
of the tumor circumference hyperintensities with DWI
could be challenging. Because, some high-grade tumor,
such as primary (de-novo) glioblastoma, show minimal
microscopic tumor infiltration in the tumor circumference
hyperintensities. A meta-analysis study reported that
DWI showed a moderate diagnostic performance for
differentiation of HGG from brain metastasis [17]. In
our study, ADCtch values and ratios were lower in HGG
than metastases, and there was a statistically significant
difference (P < 0.05).
Authors of several studies [9, 18–20] have reported that
DWI allows differentiation of lymphoma and HGG on the
basis of ADC measurements. ADCt and ADCtch values and
ratios for patients with lymphoma were substantially lower
than those for patients with HGG. Although lymphomas
had lower ADCt values compared to HGGs in our study,
there was no statistically significant difference (P > 0.05).
However, a cut-off value of 0.82 × 10−3 mm2/s for the mean
ADCtch value generated the best combination of sensitivity
78% and specificity 76% (P < 0.05) for differentiation of
HGGs and lymphoma. According to several authors, the
differences in ADC between patients with lymphoma and
those with metastasis were not statistically significant,
although the ADC for patients with lymphoma was lower
than that for patients with metastasis [2,14]. The lower
ADCt values in patients with lymphoma may have been
related to the high degree of cellularity of these tumors
leading to more restricted diffusion compared with that of
patients with other malignant brain tumors [19–21]. In our
study, the most powerful predictive marker was the mean
ADCt value in differentiation of metastasis and lymphoma.
In a variety of advanced noninvasive MRI techniques
such as spectroscopy, perfusion imaging, and diffusion
tensor imaging, we only evaluated the usefulness of ADC
measurements in the differentiation of intra-axial brain
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tumors because DWI is the cost-effective and least timeconsuming technique available in most hospitals. Data
processing is fast and relatively easy [15].
Our study has several limitations. Firstly, the
accuracy of statistical data varies due to the numerical
inhomogeneity of the current patient groups. Secondly, the
ROI placement method is subjective and may differ among
researchers. Thirdly, the geometric resolution of the ADC
maps is lower than conventional MRI. Therefore, some
difficulties are encountered in ROI placement, especially
in small-sized tumors or ring-enhancing tumors.

In conclusion, DWI with ADC measurements
contribute significantly to conventional MRI in grading
glial tumors and differentiating HGG from metastasis
and lymphoma. Detecting peritumoral invasion and
grading glial tumors, in the preoperative period, prevent
unnecessary stereotaxic biopsy, help the surgeon in
preoperative planning and may contribute to decrease in
mortality and morbidity.
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